You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR SITAGLIPTIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Sitagliptin

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00087516 ↗	Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-06-01	The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
NCT00095056 ↗	An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2004-10-01	The purpose of this study is to determine the safety and tolerability of an investigational drug in patients with Type 2 Diabetes Mellitus (a specific type of diabetes) and Chronic Renal Insufficiency (inadequate kidney function).
NCT00103857 ↗	MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2005-03-17	The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus (T2DM) (a specific type of diabetes).
NCT00127192 ↗	A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)	Completed	Merck Sharp & Dohme Corp.	Phase 2	2005-07-01	The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with type 2 diabetes mellitus.
NCT00305604 ↗	Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-03-08	To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.
NCT00337610 ↗	Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-01	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic (blood sugar) control on metformin therapy.
NCT00350779 ↗	Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-12	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin/peroxisome proliferator-activated receptor gamma (PPARg) agonist combination therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Sitagliptin

Condition Name

Chart
Table

Condition Name for Sitagliptin
Intervention	Trials
Type 2 Diabetes Mellitus	114
Diabetes Mellitus, Type 2	88
Type 2 Diabetes	71
Diabetes	24
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Sitagliptin
Intervention	Trials
Diabetes Mellitus	298
Diabetes Mellitus, Type 2	297
Diabetes Mellitus, Type 1	18
Hyperglycemia	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Sitagliptin

Trials by Country

Map
Table

Trials by Country for Sitagliptin
Location	Trials
Canada	107
India	91
China	88
Mexico	65
Korea, Republic of	53
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Sitagliptin
Location	Trials
California	73
Texas	73
Florida	68
Ohio	51
Georgia	48
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Sitagliptin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Sitagliptin
Clinical Trial Phase	Trials
Phase 4	137
Phase 3	126
Phase 2/Phase 3	10
[disabled in preview]	162
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Sitagliptin
Clinical Trial Phase	Trials
Completed	338
Unknown status	33
Terminated	30
[disabled in preview]	48
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sitagliptin

Sponsor Name

Chart
Table

Sponsor Name for Sitagliptin
Sponsor	Trials
Merck Sharp & Dohme Corp.	125
Novo Nordisk A/S	18
Eli Lilly and Company	15
[disabled in preview]	42
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Sitagliptin
Sponsor	Trials
Industry	315
Other	294
NIH	15
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.